Royal jelly ameliorates insulin resistance in fructose-drinking rats

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 11, 2008, Pages 2103-2107

  Zamami, Yoshito ^a   Takatori, Shingo ^b   Goda, Mitsuhiro ^a   Koyama, Toshihiro ^a   Iwatani, Yukiko ^a   Jin, Xin ^a   Takai Doi, Shima ^c   Kawasaki, Hiromu ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b NIPPON SHINYAKU CO LTD   (Japan)

^c Yamada Apiculture Center Inc   (Japan)

Author keywords

Fructose drinking rat; Insulin resistance; Periarterial nerve function; Royal jelly

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLESTEROL; FRUCTOSE; GLUCOSE; INSULIN; NORADRENALIN; ROYAL JELLY; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DISEASE MODEL; GLUCOSE HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT RATIO; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MORNING DOSAGE; NERVE STIMULATION; NONHUMAN; RAT; SYMPATHETIC NERVE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASOCONSTRICTION; VASODILATATION;

ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DRINKING; ELECTRIC STIMULATION; FATTY ACIDS; FRUCTOSE; HYPERTENSION; INSULIN; INSULIN RESISTANCE; MALE; MESENTERIC ARTERIES; PERFUSION; PERIPHERAL NERVOUS SYSTEM; RATS; RATS, WISTAR; TRIGLYCERIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATION;

EID: 55549096404     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.2103     Document Type: Article

References (24)

1. Matsuka M., Honeybee Science, 1, 31-41 (1980).
2. Tokunaga K. H., Yoshida C., Suzuki K. M., Maruyama H., Futamura Y., Araki Y., Mishima S., Biol. Pharm. Bull., 27, 189-192 (2004).
3. Kramer K. J., Tager H. S., Childs C. N., Speirs R. D., J. Insect. Physiol., 23, 293-295 (1977).
4. Tamura T., Fujii A., Kuboyama N., Nippon Yakurigaku Zasshi, 89, 73-80 (1987).
5. Skarfors E. T., Lithell H. O., Selinus I., J. Hypertens., 9, 217-223 (1991).
6. Haffner S. M., Valdez R. A., Hazuda H. P., Mitchell B. D., Morales P. A., Stern M. P., Diabetes, 41, 715-722 (1992).
7. Lissner L., Bengtsson C., Lapidus L., Kristjansson K., Wedel H., Hypertension, 20, 797-801 (1992).
8. Suzuki M., Nomura C., Odaka H., Ikeda H., Jpn. J. Pharmacol., 74, 297-302 (1997).
9. Tobey T. A., Mondon C. E., Zavaroni I., Reaven G. M., Metabolism, 31, 608-612 (1982).
10. Takatori S., Zamami Y., Mio M., Kurosaki Y., Kawasaki H., Hypertens. Res., 29, 361-368 (2006).
11. Takatori S., Zamami Y., Yabumae N., Hanafusa N., Mio M., Egawa T., Kawasaki H., Br. J. Pharmacol., 153, 1388-1398 (2008).
12. Nomura M., Maruo N., Zamami Y., Takatori S., Doi S., Kawasaki H., Yakugaku Zasshi, 127, 1877-1882 (2007).
13. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C., Diabetologia, 28, 412-419 (1985).
14. Rösen P., Osmers A., Horm. Metab. Res., 38, 575-586 (2006).
15. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K., Kaneko S., Metabolism, 57, 1071-1077 (2008).
16. Kumashiro N., Tamura Y., Uchida T., Ogihara T., Fujitani Y., Hirose T., Mochizuki H., Kawamori R., Watada H., Diabetes, 57, 2083-2091 (2008).
17. El-Nekeety A. A., El-Kholy W., Abbas N. F., Ebaid A., Amra H. A., Abdel-Wahhab M. A., Toxicon, 50, 256-269 (2007).
18. Guo H., Ekusa A., Iwai K., Yonekura M., Takahata Y., Morimatsu F., J. Nutr. Sci. Vitaminol., 54, 191-195 (2008).
19. Kawasaki H., Takasaki K., J. Pharmacol. Exp. Ther., 229, 816-822 (1984).
20. Kawasaki H., Urabe M., Takasaki K., Hypertension, 10, 321-327 (1987).
21. Han S. P., Naes L., Westfall T. C., Biochem. Biophys. Res. Commun., 168, 786-791 (1990).
22. Kawasaki H., Nuki C., Saito A., Takasaki K., Am. J. Physiol., 261, 683-690 (1991).
23. Kawasaki H., Takasaki K., Saito A., Goto K., Nature (London), 335, 164-167 (1988).
24. Kawasaki H., Nuki C., Saito A., Takasaki K., J. Pharmacol. Exp. Ther., 252, 403-409 (1990).